BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22998478)

  • 41. Scrapie-induced defects in learning and memory of transgenic mice expressing anchorless prion protein are associated with alterations in the gamma aminobutyric acid-ergic pathway.
    Trifilo MJ; Sanchez-Alavez M; Solforosi L; Bernard-Trifilo J; Kunz S; McGavern D; Oldstone MB
    J Virol; 2008 Oct; 82(20):9890-9. PubMed ID: 18667494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
    Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
    Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases.
    Reiniger L; Mirabile I; Lukic A; Wadsworth JD; Linehan JM; Groves M; Lowe J; Druyeh R; Rudge P; Collinge J; Mead S; Brandner S
    Acta Neuropathol Commun; 2013 May; 1(1):8. PubMed ID: 24252267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.
    Tribouillard-Tanvier D; Striebel JF; Peterson KE; Chesebro B
    J Virol; 2009 Nov; 83(21):11244-53. PubMed ID: 19710140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.
    Privat N; Levavasseur E; Yildirim S; Hannaoui S; Brandel JP; Laplanche JL; Béringue V; Seilhean D; Haïk S
    J Biol Chem; 2017 Oct; 292(40):16688-16696. PubMed ID: 28821618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How well does the CSF inform upon pathology in the brain in Creutzfeldt-Jakob and Alzheimer's diseases?
    Weller RO
    J Pathol; 2001 May; 194(1):1-3. PubMed ID: 11329133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strain specific resistance to murine scrapie associated with a naturally occurring human prion protein polymorphism at residue 171.
    Striebel JF; Race B; Meade-White KD; LaCasse R; Chesebro B
    PLoS Pathog; 2011 Sep; 7(9):e1002275. PubMed ID: 21980292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
    Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
    J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.
    Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV
    PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models.
    Arbel-Ornath M; Hudry E; Eikermann-Haerter K; Hou S; Gregory JL; Zhao L; Betensky RA; Frosch MP; Greenberg SM; Bacskai BJ
    Acta Neuropathol; 2013 Sep; 126(3):353-64. PubMed ID: 23818064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of quinacrine treatment for prion diseases.
    Barret A; Tagliavini F; Forloni G; Bate C; Salmona M; Colombo L; De Luigi A; Limido L; Suardi S; Rossi G; Auvré F; Adjou KT; Salès N; Williams A; Lasmézas C; Deslys JP
    J Virol; 2003 Aug; 77(15):8462-9. PubMed ID: 12857915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein.
    Stewart RS; Piccardo P; Ghetti B; Harris DA
    J Neurosci; 2005 Mar; 25(13):3469-77. PubMed ID: 15800202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re-transmissibility of mouse-adapted ME7 scrapie strain to ovine PrP transgenic mice.
    Babalola JA; Kim JM; Lee YJ; Park JH; Choi HS; Choi YG; Choi EK; Kim YS
    J Vet Sci; 2019 Mar; 20(2):e8. PubMed ID: 30944531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.
    Chen C; Xu XF; Zhang RQ; Ma Y; Lv Y; Li JL; Shi Q; Xiao K; Sun J; Yang XD; Shi Q; Dong XP
    Prion; 2017 Sep; 11(5):338-351. PubMed ID: 28956708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins.
    Raymond GJ; Race B; Hollister JR; Offerdahl DK; Moore RA; Kodali R; Raymond LD; Hughson AG; Rosenke R; Long D; Dorward DW; Baron GS
    J Virol; 2012 Nov; 86(21):11763-78. PubMed ID: 22915801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.